Featured

Pulmonary Hypertension

Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease Subtypes

Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease Subtypes

Because standardized approaches for echocardiographic screening are impractical for certain subgroups of people with congenital heart disease, experts offered screening adaptations for pulmonary hypertension.

Latest

Differentiating Between Acute Pulmonary Embolism and CTEPH Using Dual-Energy CT

Differentiating Between Acute Pulmonary Embolism and CTEPH Using Dual-Energy CT

Compared with patients with a negative CT, patients with chronic thromboembolic pulmonary hypertension tended to have lower dual-energy computed tomography-based parenchymal attenuation in Hounsfield unit.

Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals

Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals

In distinct situations with clear treatment goals, such as in candidates for lung transplantation, extracorporeal membrane oxygenation should be considered.

Fucoidan: A Potent Natural Adjuvant Representing a Possible Therapy in PAH

Fucoidan: A Potent Natural Adjuvant Representing a Possible Therapy in PAH

Chronic hypoxia-exposed mice that were given fucoidans exhibited improved vascular remodeling and right ventricular function.

Endothelial Colony Forming Cells in PAH Restore Myocardial Vascular Density

Endothelial Colony Forming Cells in PAH Restore Myocardial Vascular Density

In patients with pulmonary arterial hypertension, endothelial colony forming cell transplantation was associated with restoration of myocardial vascular density.

Elevated Myocardial T1 Associated With Increased Septal Angle in PAH

Elevated Myocardial T1 Associated With Increased Septal Angle in PAH

Elevated levels of myocardial native T1 are associated with increased interventricular septal angle in patients with pulmonary hypertension.

Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH

Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH

LIQ861, an inhaled dry powder formulation of treprostinil, was well tolerated in patients with pulmonary arterial hypertension at a 2-week time point in the phase 3 clinical trial, INSPIRE.

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease

PAH: An Under-Recognized Complication of Adult-Onset Still's Disease

PAH is an under-diagnosed complication of adult-onset Still disease.

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension

Prognostic Relevance of Cardiopulmonary Exercise Testing in Low-Risk Pulmonary Arterial Hypertension

Combinations of VO2 and change in CI during follow-up visits are valuable prognosis markers in low-risk patients with PAH.

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?

Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?

Pre-existing pulmonary hypertension does not appear to affect outcomes in transcatheter mitral valve repair with the Mitraclip device.

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD

Systemic Sclerosis-Associated PAH Genomic Signature Differs From ILD

Systemic sclerosis-associated pulmonary hypertension and systemic sclerosis-associated interstitial lung disease exhibit similar but distinct gene expression profiles.

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension

Treprostinil May Have Antithrombotic Effect in Pediatric Pulmonary Hypertension

Treatment with treprostinil has demonstrated potential antithrombotic mechanisms of action in pediatric patients with pulmonary arterial hypertension.

Patient Age Linked With Specific PAH Clinical Profile and Prognosis

Patient Age Linked With Specific PAH Clinical Profile and Prognosis

Patients with pulmonary hypertension age ≥65 years have worse long-term survival compared with younger patients.

PAH Survival May Increase Risk for Pulmonary Artery Aneurysms

PAH Survival May Increase Risk for Pulmonary Artery Aneurysms

The time course of pulmonary arterial hypertension was an independent risk factor for pulmonary artery aneurysms.

Exercise Capacity in CTEPH Improved With Treprostinil

Exercise Capacity in CTEPH Improved With Treprostinil

Compared with the low dose, high-dose subcutaneous treprostinil increased 6-minute walk distances in patients with chronic thromboembolic pulmonary hypertension.

Comorbid Mental Disorder Prevalence Higher in Pulmonary Arterial Hypertension

Comorbid Mental Disorder Prevalence Higher in Pulmonary Arterial Hypertension

People with pulmonary arterial hypertension display higher levels of depression and anxiety than previously estimated by healthcare workers.

Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease Subtypes

Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease Subtypes

Because standardized approaches for echocardiographic screening are impractical for certain subgroups of people with congenital heart disease, experts offered screening adaptations for pulmonary hypertension.

Pulmonary Thromboendarterectomy Curative for CTEPH Linked to APS

Pulmonary Thromboendarterectomy Curative for CTEPH Linked to APS

Pulmonary thromboendarterectomy appears to be a curative resolution in patients with antiphospholipid syndrome related to chronic thromboembolic pulmonary hypertension.

Exercise Oxygen Desaturation, Pulmonary Function Predict Outcomes in SSc-PH

Exercise Oxygen Desaturation, Pulmonary Function Predict Outcomes in SSc-PH

Factors associated with a higher risk for mortality included male sex, exercise desaturation, and diffusing capacity of the lungs for carbon monoxide <50%.

Pulmonary Vascular Disease and Late Respiratory Disease Link in Preterm Infants

Pulmonary Vascular Disease and Late Respiratory Disease Link in Preterm Infants

Preterm infants who need mechanical ventilation at day 7 and early echocardiographic evidence of pulmonary vascular disease are strong risk factors for late respiratory disease.

Follow-Up Hemodynamics in Systemic Sclerosis-PAH Associated With 1-Year Outcomes

Follow-Up Hemodynamics in Systemic Sclerosis-PAH Associated With 1-Year Outcomes

At follow-up, the 6-minute walk distance, cardiac index, stroke volume index, and other hemodynamic variables were independently associated with transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension.

Sign Up for Free e-newsletters